SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-18-001712
Filing Date
2018-02-13
Accepted
2018-02-13 17:06:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13G sc13g0218a4cfwood_north.htm SC 13G/A 79816
  Complete submission text file 0001213900-18-001712.txt   81519
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Subject) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-62381 | Film No.: 18604654
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 0044 845922 0044
CF Woodford Equity Income Fund (Filed by) CIK: 0001637243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A